Trend Press Wire

eClinical Solutions Market Overview, Development Status and Outlook to 2026

Press release   •   Jan 02, 2020 06:25 EST

The global eClinical Solutions Market Size is set to reach over US$ 9,756 million by 2026 and will grow at CAGR 9.7% during the forecast period 2019-2026. Acumen Research and Consulting, Latest Research Report on titled “eClinical Solutions Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026”.

In the coming years, the global eClinical Solutions Market will continue exhibiting growth at a stable pace. The report offers a comprehensive overview of the market, covering growth drivers as well as restraints. It reveals hidden opportunities across key segments. Furthermore, the report highlights prevailing threats in the market. It is compiled with the most relevant information on the market to help companies determine their future growth strategies.

Information thus included in the report is obtained using diverse primary and secondary research methods. The report also includes interview of industry veterans. Their opinion is given due weightage in the study. In addition to this, the report includes statistics taken from various international organizations. This is done with the intent of studying the global market for the period starting from 2019 to 2026. These figures are reached using in-depth qualitative and quantitative analysis.

Competitive Landscape

In order to offer an executive level blueprint of the global eClinical Solutions Market, the report studies in detail the prevailing competitive landscape. The nature of competition prevailing in the global market is studied. Factors resulting into competitive rivalry among leading players are gauges as well. In this section, the report includes information obtained from various companies. Information on their product portfolio and pricing strategy is included in this section. Furthermore, the report highlights the impact of strategies adopted by these companies on this market.

Bargaining power of supplier and buyers are calculated using Porter’s five forces analysis. Furthermore, the study, helps at calculating the threat from close substitutes as well as new entrants.

Download a Free Sample Copy@ https://www.acumenresearchandconsulting.com/request-sample/1637

List of Companies

To offer a comprehensive overview, the report profiles some of the most prominent names in the industry. The market share of the global eClinical Solutions Market is dominated by companies like Oracle Corporation, Medidata Solutions, Inc., Parexel International Corporation, Bioclinica, Inc. (A Subsidiary of Cinven), Datatrak International, Inc., CRF Health, ERT Clinical, Merge Healthcare Incorporated, Omnicomm Systems, Inc., Maxisit Inc., Bio-Optronics, Inc., and Eclinical Solutions, LLC. They are studied on the basis of their corporate policies, product portfolio, pricing strategies, recent mergers and acquisition, and various other criteria. Furthermore, recent developments witnessed in these companies in terms of recent investment, product launches, and collaborations are studied in the report in detail.

The strengths and weaknesses of the companies profiled are studied in detail. Furthermore, the report offers scope for analysing threats and opportunities existing in the market for the companies profiled.

Geography

The global eClinical Solutions Market can be segmented into Europe, Asia Pacific, North America, Latin America, and the Middle East and Africa.

Among key regional segments, the market is likely to witness lucrative growth opportunities in developed economies. The presence of a well-developed healthcare network is expected to support the growth of the market in these countries. Developed countries have attained the status of early adopters. While several leading companies have presence here, they are gradually shifting focus to capitalize on the prevailing opportunities in the emerging nations.

Various factors are supporting the growth witnessed across these countries. Firstly, the rise in spread of awareness is expected to bode well for the eClinical Solutions Market in emerging economies. Furthermore, in Asia Pacific government support towards the sector as well as investment towards expanding the healthcare and pharmaceutical industries is increasing. This is expected to drive the eClinical Solutions Market in Asia Pacific.

To offer an executive-level blueprint, the report calculates market share held by each of these regions. Furthermore, it identifies the leading region in this market.

Segments

The report segments the eClinical Solutions Market in terms of various parameters. The leading segment in each of these categories is identified in the study. Furthermore, their potential CAGR is calculated. In addition to this, the report offers insights into growth drivers and key restraints that are likely to impact the market across various segments.

Market Segmentations as below:

Market by Product

  • Electronic Data Capture and Clinical Data Management Systems
  • Clinical Trial Management Systems
  • Clinical Analytics Platforms
  • Randomization and Trial Supply Management
  • Clinical Data Integration Platforms
  • Electronic Clinical Outcome Assessment Solutions
  • Safety Solutions
  • Electronic Trial Master File Systems
  • Regulatory Information Management Solutions
  • Others

Market by Delivery Mode

  • Web-Hosted (On-Demand) Solutions
  • Licensed Enterprise (On-Premise) Solutions
  • Cloud-Based (SaaS) Solutions

Market by Clinical Trial Phase

  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV Clinical Trials

Market by End-use

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Research Organizations
  • Consulting Service Companies
  • Medical Device Manufacturers
  • Hospitals
  • Academic Research Institutes

Market By Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Key Takeaways:

  • What is the market size in 2018 and the growth rate of this research report?
  • What is the market drivers, restrains, opportunities governing the global eClinical Solutions Market?
  • Which is the largest and the fastest growing segments in this report?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of eClinical Solutions
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. eClinical Solutions Market By Product
1.2.2.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global eClinical Solutions Market Revenue Share By Product in 2018
1.2.2.3. Electronic Data Capture and Clinical Data Management Systems
1.2.2.4. Clinical Trial Management Systems
1.2.2.5. Clinical Analytics Platforms
1.2.2.6. Randomization and Trial Supply Management
1.2.2.7. Clinical Data Integration Platforms
1.2.2.8. Electronic Clinical Outcome Assessment Solutions
1.2.2.9. Safety Solutions
1.2.2.10. Electronic Trial Master File Systems
1.2.2.11. Regulatory Information Management Solutions
1.2.2.12. Others
1.2.3. eClinical Solutions Market By Delivery Mode
1.2.3.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By Delivery Mode (2015-2026)
1.2.3.2. Web-Hosted (On-Demand) Solutions
1.2.3.3. Licensed Enterprise (On-Premise) Solutions
1.2.3.4. Cloud-Based (SaaS) Solutions
1.2.4. eClinical Solutions Market By Clinical Trial Phase
1.2.4.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By Clinical Trial Phase (2015-2026)
1.2.4.2. Phase I Clinical Trials
1.2.4.3. Phase II Clinical Trials
1.2.4.4. Phase III Clinical Trials
1.2.4.5. Phase IV Clinical Trials
1.2.5. eClinical Solutions Market By End-use
1.2.5.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By End-user (2015-2026)
1.2.5.2. Pharmaceutical and Biopharmaceutical Companies
1.2.5.3. Contract Research Organizations
1.2.5.4. Consulting Service Companies
1.2.5.5. Medical Device Manufacturers
1.2.5.6. Hospitals
1.2.5.7. Academic Research Institutes
1.2.6. eClinical Solutions Market By Geography
1.2.6.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America eClinical Solutions Market Revenue and Growth Rate(2015-2026)
1.2.6.3. Europe eClinical Solutions Market Revenue and Growth Rate(2015-2026)
1.2.6.4. Asia-Pacific eClinical Solutions Market Revenue and Growth Rate(2015-2026)
1.2.6.5. Latin America eClinical Solutions Market Revenue and Growth Rate(2015-2026)
1.2.6.6. Middle East and Africa (MEA) eClinical Solutions Market Revenue and Growth Rate(2015-2026)

CHAPTER 2. MARKET DYNAMICSAND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global eClinical Solutions Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global eClinical Solutions Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global eClinical Solutions Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global eClinical Solutions Major Manufacturers in 2018

CHAPTER 4. ECLINICAL SOLUTIONS MARKET BY PRODUCT
4.1. Global eClinical Solutions Revenue By Product
4.2. Electronic Data Capture and Clinical Data Management Systems
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Clinical Trial Management Systems
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Clinical Analytics Platforms
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Randomization and Trial Supply Management
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Clinical Data Integration Platforms
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Electronic Clinical Outcome Assessment Solutions
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.8. Safety Solutions
4.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.9. Electronic Trial Master File Systems
4.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.10. Regulatory Information Management Solutions
4.10.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.10.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.11. Others
4.11.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.11.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE
5.1. Global eClinical Solutions Revenue By Delivery Mode
5.2. Web-Hosted (On-Demand) Solutions
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Licensed Enterprise (On-Premise) Solutions
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Cloud-Based (SaaS) Solutions
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE
6.1. Global eClinical Solutions Revenue By Clinical Trial Phase
6.2. Phase I Clinical Trials
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Phase II Clinical Trials
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Phase III Clinical Trials
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Phase IV Clinical Trials
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. ECLINICAL SOLUTIONS MARKET By End-use
7.1. Global eClinical Solutions Revenue By End-use
7.2. Pharmaceutical and Biopharmaceutical Companies
7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Contract Research Organizations
7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Consulting Service Companies
7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.5. Medical Device Manufacturers
7.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.6. Hospitals
7.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.7. Academic Research Institutes
7.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. NORTH AMERICA ECLINICAL SOLUTIONS MARKET BY COUNTRY
8.1. North America eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
8.3.1. U.S. eClinical Solutions Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
8.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
8.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 9. EUROPE ECLINICAL SOLUTIONS MARKET BY COUNTRY
9.1. Europe eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.6.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.7.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 10. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET BY COUNTRY
10.1. Asia-Pacific eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.6.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.6.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.6.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.7.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.7.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.7.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.8.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.8.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.8.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 11. LATIN AMERICA ECLINICAL SOLUTIONS MARKET BY COUNTRY
11.1. Latin America eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
11.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.4. Mexico
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
11.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
11.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 12. MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET BY COUNTRY
12.1. Middle East & Africa eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East & Africa eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. GCC
12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
12.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
12.4. South Africa
12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
12.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
12.5. Rest of Middle East & Africa
12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
12.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE
13.1. Oracle Corporation
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Medidata Solutions, Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Parexel International Corporation
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Bioclinica, Inc. (A Subsidiary of Cinven)
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Datatrak International, Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. CRF Health
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. ERT Clinical
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Merge Healthcare Incorporated
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Omnicomm Systems, Inc.
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Maxisit Inc.
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Bio-Optronics, Inc.
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. Others
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Type Portfolio
13.12.5. Key Developments
13.12.6. Strategies

CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1637

Contact Us:

Acumen Research and Consulting

Phone: +1 407 915 4157

Email: sales@acumenresearchandconsulting.com

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.